Association study of high-frequency variants of MTHFR gene with retinal vein occlusion in a Spanish population

References

• Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten year incidence of retinal vein occlusion in an older population: The blue mountains eye study. Arch Ophthalmol. 2006;124:726–32. doi:10.1001/archopht.124.5.726.
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Amoaku WM, Hykin P; RVO Guideline Group. The Royal College of ophthalmologists guidelines on retinal vein occlusions: executive summary. Eye (Lond). 2015;29(12):1633–38. doi:10.1038/eye.2015.164.
   PubMed Web of Science ®Google Scholar
• The eye disease case–control study group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol. 1993;116:286–96. doi:10.1016/S0002-9394(14)71345-5.
   PubMed Web of Science ®Google Scholar
• Martinez F, Furio E, Fabia MJ, Pérez AV, González-Albert V, Rojo-Martínez G, Martínez-Larrad MT, Mena-Martín FJ, Soriguer F, Serrano-Ríos M, et al. Risk factors associated with retinal vein occlusion. Int J Clin Pract. 2014;68:871–81.
   PubMed Web of Science ®Google Scholar
• Stem MS, Talwar N, Comer GM, Stein JD. A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology. 2013;120:362–70. doi:10.1016/j.ophtha.2012.07.080.
   PubMed Web of Science ®Google Scholar
• Janssen MC, Den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost. 2005;93:1021–26. doi:10.1160/TH04-11-0768.
   PubMed Web of Science ®Google Scholar
• Gori AM, Marcucci R, Fatini C, Gensini F, Sticchi E, Sodi A, Cappelli S, Menchini U, Gensini GF, Abbate R, et al. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels. Thromb Haemost. 2004;92:54–60. doi:10.1160/TH03-08-0509.
   PubMed Web of Science ®Google Scholar
• Hansen L, Kristensen HL, Bek T, Ingerslev J. Markers of thrombophilia in retinal vein thrombosis. Acta Ophthalmol Scand. 2000;78:523–26. doi:10.1034/j.1600-0420.2000.078005523.x.
   PubMedGoogle Scholar
• Salomon O, Moisseiev J, Rosenberg N, Vidne O, Yassur I, Zivelin A, Treister G, Steinberg DM, Seligsohn U. Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul Fibrinolysis. 1998;9:617–22. doi:10.1097/00001721-199810000-00008.
   PubMed Web of Science ®Google Scholar
• Greiner K, Hafner G, Dick B, Peetz D, Prellwitz W, Pfeiffer N. Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol. 1999;128:69–74. doi:10.1016/S0002-9394(99)00074-4.
   PubMed Web of Science ®Google Scholar
• Yioti GG, Panagiotou OA, Vartholomatos GA, Kolaitis NI, Pappa CN, Evangelou E, Stefaniotou MI. Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis. Ophthalmic Genet. 2013; 34(3):130–39. doi:10.3109/13816810.2012.746376.
   PubMed Web of Science ®Google Scholar
• McGimpsey SJ, Woodside JV, Cardwell C, Cahill M, Chakravarthy U. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis. Ophthalmology. 2009; 116(9):1778–1787.e1. doi:10.1016/j.ophtha.2009.02.033.
   PubMed Web of Science ®Google Scholar
• Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolatereductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9. doi:10.1161/01.CIR.93.1.7.
   PubMed Web of Science ®Google Scholar
• D’Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolatereductase (MTHFR) gene. A case-control study of patients withearly-onset thrombotic events. Thromb Haemost. 2000; 83(4):563–70. doi:10.1055/s-0037-1613864.
   PubMed Web of Science ®Google Scholar
• Frosst P, HJ B, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, Den Heijer M, Kluijtmans LA, van Den Heuvel LP, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–13. doi:10.1038/ng0595-111.
   PubMed Web of Science ®Google Scholar
• Harmon DL, Woodside JV, Yarnell JW, McMaster D, Young IS, McCrum EE, Gey KF, Whitehead AS, Evans AE. The common ‘thermolabile’ variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM. 1996; 89(8):571–77. doi:10.1093/qjmed/89.8.571.
   PubMedGoogle Scholar
• Varga EA, Sturm AC, Misita CP, Moll S. Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. Circulation. 2005; 111(19):e289–e293. doi:10.1161/01.CIR.0000165142.37711.E7.
   PubMed Web of Science ®Google Scholar
• Li D, Zhou M, Peng X, Sun H. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis. BMC Ophthalmol. 2014;14:147. doi:10.1186/1471-2415-14-147.
   PubMed Web of Science ®Google Scholar
• Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64:169–72. doi:10.1006/mgme.1998.2714.
   PubMed Web of Science ®Google Scholar
• Ferrazzi P, Di Micco P, Quaglia I, Rossi LS, Bellatorre AG, Gaspari G, Rota LL, Lodigiani C. Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion. Thromb J. 2005;3:13. doi:10.1186/1477-9560-3-13.
   PubMedGoogle Scholar
• Minniti G, Calevo MG, Giannattasio A, Camicione P, Armani U, Lorini R, Piana G. Plasma homocysteine in patients with retinal vein occlusion. Eur J Ophthalmol. 2014; 24(5):735–43. doi:10.5301/ejo.5000426.
   PubMed Web of Science ®Google Scholar
• Sottilotta G, Siboni SM, Latella C, Oriana V, Romeo E, Santoro R, Consonni D, Trapani Lombardo V. Hyperhomocysteinemia and C677T MTHFR genotype in patients with retinal vein thrombosis. Clin Appl Thromb Hemost. 2010;16:549–53. doi:10.1177/1076029609348644.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Bell H, Vadlamani L, Gupta A, Fontaine RN, Wang P, Stroop D, Gruppo R. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol. 1999; 117(1):43–49. doi:10.1001/archopht.117.1.43.
   PubMedGoogle Scholar
• Adamczuk YP, Iglesias Varela ML, Martinuzzo ME, Cerrato GS, Forastiero RR. Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis. 2002;13:623–26.
   PubMed Web of Science ®Google Scholar
• Mrad M, Wathek C, Saleh MB, Baatour M, Rannen R, Lamine K, Gabsi S, Gritli N, Fekih-Mrissa N. Association of methylenetetrahydrofolate reductase (A1298C and C677T) polymorphisms with retinal vein occlusion in Tunisian patients. Transfus Apher Sci. 2014; 50(2):283–87. doi:10.1016/j.transci.2013.12.016.
   PubMed Web of Science ®Google Scholar
• Dong N, Wang B, Chu L, Xiao L. Plasma homocysteine concentrations in the acute phase after central retinal vein occlusion in a Chinese population. Curr Eye Res. 2013; 38(11):1153–58. doi:10.3109/02713683.2013.809124.
   PubMed Web of Science ®Google Scholar
• Pulido JS, Flaxel CJ, Adelman RA, Hyman L, Folk JC, Olsen TW. Retinal vein occlusions preferred practice pattern(®) guidelines. Ophthalmology. 2016; 123(1):182–208. doi:10.1016/j.ophtha.2015.10.045.
   Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–65. doi:10.1093/bioinformatics/bth457.
   PubMed Web of Science ®Google Scholar
• Armitage P, Berry G, Matthews J. Statistical methods in medical research. Oxford (UK): Wiley; 2002. ISBN: 978-0-632-05257-8.
   Google Scholar
• Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001; 131(1):61–77. doi:10.1016/s0002-9394(00)00709-1.
   PubMed Web of Science ®Google Scholar
• Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP, Poli D, Pepe G, Abbate R, Prisco D. Thrombophilic risk factors in patients with central retinal vein occlusion. Thomb Haemost. 2001; 86(3):772–76. doi:10.1055/s-0037-1616130.
   PubMed Web of Science ®Google Scholar
• Marcucci R, Giusti B, Betti I, Evangelisti L, Fedi S, Sodi A, Cappelli S, Menchini U, Abbate R, Prisco D. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion. Thromb Res. 2003;110:7–12. doi:10.1016/S0049-3848(03)00293-7.
   PubMed Web of Science ®Google Scholar
• Russo DL, Damante G, Pasca S, Turello M, Barillari G. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study. Clin Appl Thromb Hemost. 2015; 21(4):373–77. doi:10.1177/1076029614522544.
   PubMed Web of Science ®Google Scholar
• Di Crecchio L, Parodi MB, Sanguinetti G, Iacono P, Ravalico G. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion. Ophthalmology. 2004;111:940–45. doi:10.1016/j.ophtha.2003.08.028.
   PubMed Web of Science ®Google Scholar
• Di Capua M, Coppola A, Albisinni R, Tufano A, Guida A, Di Minno MN, Cirillo F, Loffredo M, Cerbone AM. Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis. 2010; 30(1):16–22. doi:10.1007/s11239-009-0388-1.
   PubMed Web of Science ®Google Scholar
• Giannaki K, Politou M, Rouvas A, Merkouri E, Travlou A, Theodosiadis P, Gialeraki A. Retinal vein occlusion: genetic predisposition and systemic risk factors. Blood Coagul Fibrinolysis. 2013; 24(3):279–83. doi:10.1097/MBC.0b013e32835bfda1.
   PubMed Web of Science ®Google Scholar
• Cahill M, Karabatzaki M, Donoghue C, Meleady R, Mynett-Johnson LA, Mooney D, Graham IM, Whitehead AS, Shields DC. Thermolabile MTHFR genotype and retinal vascular occlusive disease. Br J Ophthalmol. 2001;85(1):88–90. doi:10.1136/bjo.85.1.88.
   PubMed Web of Science ®Google Scholar
• McGimpsey SJ, Woodside JV, Bamford L, Gilchrist SE, Graydon R, McKeeman GC, Young IS, Hughes AE, Patterson CC, O’Reilly D, et al. Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype. Invest Ophthalmol Vis Sci. 2005; 46(12):4712–16. doi:10.1167/iovs.04-1229.
   PubMed Web of Science ®Google Scholar
• Koylu MT, Kucukevcilioglu M, Erdurman FC, Durukan AH, Sobacı G, Torun D, Tunca Y, Ayyildiz O. Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: A case-control study. Ophthalmic Genet. 2017; 38(4):352–56. doi:10.1080/13816810.2016.1235716.
   PubMed Web of Science ®Google Scholar
• Boyd S, Owens D, Gin T, Bunce K, Sherafat H, Perry D, Hykin PG. Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol. 2001; 85(11):1313–15. doi:10.1136/bjo.85.11.1313.
   PubMed Web of Science ®Google Scholar
• Dodson PM, Haynes J, Starczynski J, Farmer J, Shigdar S, Fegan G, Johnson RJ, Fegan C. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion. Eye (Lond). 2003; 17(6):772–77. doi:10.1038/sj.eye.6700452.
   PubMed Web of Science ®Google Scholar
• Larsson J, Hultberg B, Hillarp A. Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion. Acta Ophthalmol Scand. 2000; 78(3):340–43. doi:10.1034/j.1600-0420.2000.078003340.x.
   PubMedGoogle Scholar
• Weger M, Stanger O, Deutschmann H. Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology. 2002;109(6):1105–09. doi:10.1016/s0161-6420(02)01044-8.
   PubMed Web of Science ®Google Scholar
• Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002; 240(4):286–90. doi:10.1007/s00417-002-0431-9.
   PubMed Web of Science ®Google Scholar
• Biancardi AL, Gadelha T, Sergillo Borges WI, Vieira de Moraes H, Spector N. Thrombophilic mutations and risk of retinal vein occlusion. Arq Bras Oftalmol. 2007; 70(6):971–74. doi:10.1590/S0004-27492007000600016.
   PubMedGoogle Scholar
• Gao W, Wang YS, Zhang P, Wang HY. MTHFR C677T mutation in central retinal vein occlusion: a case-control study in Chinese population. Thromb Res. 2008; 121(5):699–703. doi:10.1016/j.thromres.2007.05.026.
   PubMed Web of Science ®Google Scholar
• Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol. 2003; 136(6):1136–50. doi:10.1016/s0002-9394(03)00571-3.
   PubMed Web of Science ®Google Scholar
• Loewenstein A, Goldstein M, Winder A, Lazar M, Eldor A. Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology. 1999; 106(9):1817–20. doi:10.1016/S0161-6420(99)90357-3.
   PubMed Web of Science ®Google Scholar
• Al-Nawaiseh B, Al-Madani M. Risk factors for central and branch retinal vein occlusion. MEJFM. 2006;4(2):29–32.
   Google Scholar
• Soltanpour MS, Soheili Z, Shakerizadeh A, Pourfathollah AA, Samiei S, Meshkani R, Shahjahani M, Karimi A. Methylenetetrahydrofolate reductase C677T mutation and risk of retinal vein thrombosis. J Res Med Sci. 2013;18(6):487–91. PMID:24250697.
   PubMed Web of Science ®Google Scholar
• Ghaznavi H, Soheili Z, Samiei S, Soltanpour MS. Plasma homocysteine levels, methylene tetrahydrofolate reductase A1298C gene polymorphism and risk of retinal vein thrombosis. Blood Coagul Fibrinolysis. 2016; 27(6):679–83. doi:10.1097/MBC.0000000000000476.
   PubMed Web of Science ®Google Scholar
• The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526:68–74. doi:10.1038/nature15393.
   PubMed Web of Science ®Google Scholar
• Rogers S, McIntosh RL, Cheung N, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY; International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. 2010;117(2):313–319.e1. doi:10.1016/j.ophtha.2009.07.017.
   Google Scholar
• Laouri M, Chen E, Looman M, Gallagher M. The burden of disease of retinal vein occlusion: review of the literature. Eye (Lond). 2001; 25(8):981–88. doi:10.1038/eye.2011.92.
   Google Scholar